Population-based incidence of Type 2 diabetes and its associated risk factors: Results from a six-year cohort study in Iran

BMC Public Health

Volumn 9, Issue , 2009, Pages

  Harati, Hadi ^a   Hadaegh, Farzad ^a   Saadat, Navid ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INCIDENCE; IRAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; RISK FACTOR; SEX RATIO; AGED; ANTHROPOMETRY; COHORT ANALYSIS; COMPARATIVE STUDY; HEALTH SURVEY; MIDDLE AGED; QUESTIONNAIRE; URBAN POPULATION;

ADULT; AGED; ANTHROPOMETRY; BODY MASS INDEX; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INCIDENCE; IRAN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; QUESTIONNAIRES; RISK FACTORS; URBAN POPULATION;

EID: 68149180707     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-9-186     Document Type: Article

References (28)

1. International Diabetes Federation: a consensus on Type 2 diabetes prevention. KG Alberti P Zimmet J Shaw, Diabet Med 2007 24 451 463 17470191 10.1111/j.1464-5491.2007.02157.x (Pubitemid 46669328)
2. Diabetes Atlas Brussels: International Diabetes Federation 2006
3. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. S Wild G Roglic A Green R Sicree H King, Diabetes Care 2004 27 1047 1053 15111519 10.2337/diacare.27.5.1047 (Pubitemid 38579764)
4. Global and societal implications of the diabetes epidemic. P Zimmet KG Alberti J Shaw, Nature 2001 414 782 787 11742409 10.1038/414782a (Pubitemid 34000780)
5. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. WC Knowler E Barrett-Connor SE Fowler RF Hamman JM Lachin EA Walker DM Nathan, N Engl J Med 2002 346 393 403 11832527 10.1056/NEJMoa012512 (Pubitemid 34437694)
6. Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates. H Saadi SG Carruthers N Nagelkerke F Al-Maskari B Afandi R Reed M Lukic MG Nicholls E Kazam K Algawi, Diabetes Res Clin Pract 2007 78 369 377 17532085 10.1016/j.diabres.2007.04.008 (Pubitemid 350030313)
7. Increasing prevalence of diabetes mellitus in Oman. JA Al-Lawati AM Al Riyami AJ Mohammed P Jousilahti, Diabet Med 2002 19 954 957 12421434 10.1046/j.1464-5491.2002.00818.x (Pubitemid 35356923)
8. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. A Esteghamati MM Gouya M Abbasi A Delavari S Alikhani F Alaedini A Safaie M Forouzanfar EW Gregg, Diabetes Care 2008 31 96 98 17921357 10.2337/dc07-0959
9. High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. F Hadaegh MR Bozorgmanesh A Ghasemi H Harati N Saadat F Azizi, BMC Public Health 2008 8 176 18501007 10.1186/1471-2458-8-176 (Pubitemid 351810406)
10. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). F Azizi M Rahmani H Emami P Mirmiran R Hajipour M Madjid J Ghanbili A Ghanbarian Y Mehrabi N Saadat, Soz Praventivmed 2002 47 408 426 12643001 (Pubitemid 36285040)
11. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997 20 1183 1197 9203460
12. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002 106 3143 3421 12485966
13. Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study. E Bonora S Kiechl J Willeit F Oberhollenzer G Egger JB Meigs RC Bonadonna M Muggeo, Diabetes 2004 53 1782 1789 15220202 10.2337/diabetes.53.7.1782 (Pubitemid 38857036)
14. Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 19902000. NG Forouhi J Luan S Hennings NJ Wareham, Diabet Med 2007 24 200 207 17257284 10.1111/j.1464-5491.2007.02068.x (Pubitemid 46174945)
15. Population-based incidence of type 2 diabetes in northern Spain: the Asturias Study. S Valdes P Botas E Delgado F Alvarez FD Cadorniga, Diabetes Care 2007 30 2258 2263 17536076 10.2337/dc06-2461 (Pubitemid 47359028)
16. Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian Diabetes, Obesity and Lifestyle Study. DJ Magliano EL Barr PZ Zimmet AJ Cameron DW Dunstan S Colagiuri D Jolley N Owen P Phillips RJ Tapp, Diabetes Care 2008 31 267 272 17989310 10.2337/dc07-0912 (Pubitemid 351213333)
17. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. F de Vegt JM Dekker A Jager E Hienkens PJ Kostense CD Stehouwer G Nijpels LM Bouter RJ Heine, Jama 2001 285 2109 2113 11311100 10.1001/jama.285.16.2109
18. Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. FL Brancati WH Kao AR Folsom RL Watson M Szklo, Jama 2000 283 2253 2259 10807384 10.1001/jama.283.17.2253
19. Rapid rise in the incidence of type 2 diabetes from 1987 to 1996: results from the San Antonio Heart Study. JP Burke K Williams SP Gaskill HP Hazuda SM Haffner MP Stern, Arch Intern Med 1999 159 1450 1456 10399896 10.1001/archinte.159.13.1450 (Pubitemid 29302885)
20. Effects of changing diagnostic criteria on the risk of developing diabetes. SF Dinneen D Maldonado 3rd CL Leibson GG Klee H Li LJ Melton 3rd RA Rizza, Diabetes Care 1998 21 1408 1413 9727885 10.2337/diacare.21.9.1408
21. Obesity and diabetes in the developing world a growing challenge. P Hossain B Kawar M El Nahas, N Engl J Med 2007 356 213 215 17229948 10.1056/NEJMp068177 (Pubitemid 46143224)
22. An accelerated nutrition transition in Iran. H Ghassemi G Harrison K Mohammad, Public Health Nutr 2002 5 149 155 12027278 10.1079/PHN2001287 (Pubitemid 41128301)
23. Temporal changes in anthropometric parameters and lipid profile according to body mass index among an adult Iranian urban population. MR Bozorgmanesh F Hadaegh M Padyab Y Mehrabi F Azizi, Ann Nutr Metab 2008 53 13 22 18772585 10.1159/000152869
24. Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose. JJ Wang SY Yuan LX Zhu HJ Fu HB Li G Hu J Tuomilehto, Diabetes Res Clin Pract 2004 66 183 191 15533586 10.1016/j.diabres.2004.03.002 (Pubitemid 39469346)
25. High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. S Soderberg P Zimmet J Tuomilehto M de Courten GK Dowse P Chitson H Stenlund H Gareeboo KG Alberti J Shaw, J Intern Med 2004 256 37 47 15189364 10.1111/j.1365-2796.2004.01336.x (Pubitemid 38813618)
26. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. N Unwin J Shaw P Zimmet KG Alberti, Diabet Med 2002 19 708 723 12207806 10.1046/j.1464-5491.2002.00835.x (Pubitemid 35013848)
27. Impaired fasting glucose cutoff value of 5.6 mmol/l combined with other cardiovascular risk markers is a better predictor for incident Type 2 diabetes than the 6.1 mmol/l value: Tehran Lipid and Glucose Study. H Harati F Hadaegh M Tohidi F Azizi, Diabetes research and Clinical Practice 2009
28. Seven-year changes in physical fitness, physical activity, and lipid profile in the CARDIA study. Coronary Artery Risk Development in Young Adults. B Sternfeld S Sidney DR Jacobs Jr MC Sadler WL Haskell PJ Schreiner, Ann Epidemiol 1999 9 25 33 9915606 10.1016/S1047-2797(98)00030-1 (Pubitemid 29016702)